CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 40 enrolled
Drug / intervention
tacrolimus +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00374231
NCT00374231Phase 4Completed

A Single Center, Pilot Study of Corticosteroid Discontinuation in Liver Transplant Recipients Utilizing a Tacrolimus/Mycophenolate Mofetil Based Maintenance Immunosuppression Protocol

University of Cincinnati·interventional·Posted Sep 11, 2006·Updated Dec 29, 2015

In Brief

A Phase 4 clinical trial evaluating tacrolimus, mycophenolate mofetil, and 1 other intervention for Liver Transplantation. Completed, enrolled 40 participants across 1 site.

Detailed Summary

To determine the safety and efficacy of early corticosteroid discontinuation in liver transplant recipients more than 90 days post transplant, utilizing a combination of two drugs (tacrolimus and mycophenolate mofetil) for maintenance immunosuppressant therapy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsAstellas Pharma Inc

Timeline

Phase 4CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 11, 2006
Enrollment StartOct 1, 2002
Primary CompletionJan 1, 2008
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 19.8 years ago

Interventions

tacrolimusdrug

Tacrolimus is a pill taken orally. Dose, frequency and duration will be decided by the study doctor on a case-by-case basis.

mycophenolate mofetildrug

Mycophenolate mofetil is a pill taken orally. Dose, frequency and duration will be decided by the study doctor on a case-by-case basis.

Prednisonedrug

Prednisone is a pill taken orally. Dose, frequency and duration will be decided by the study doctor on a case-by-case basis.